US 11,998,596 B2
Immunogenic compositions and vaccines comprising African swine fever virus peptides and proteins and uses thereof
Veljko Nikolin, Hannover (DE); Egbert Siegfried Mundt, Isernhagen (DE); Fernando Rodriguez Gonzalez, Barcelona (ES); Laia Bosch Camos, Barcelona (ES); and Javier Alonso Collado Miguens, Barcelona (ES)
Filed by Boehringer Ingelheim Vetmedica GmbH, Ingelheim am Rhein (DE)
Filed on Dec. 16, 2022, as Appl. No. 18/067,614.
Application 18/067,614 is a division of application No. 16/830,412, filed on Mar. 26, 2020, granted, now 11,628,214.
Claims priority of application No. 19382216 (EP), filed on Mar. 27, 2019.
Prior Publication US 2023/0277648 A1, Sep. 7, 2023
Int. Cl. A61K 39/12 (2006.01); C12N 15/74 (2006.01); C12N 15/86 (2006.01); A61K 39/00 (2006.01)
CPC A61K 39/12 (2013.01) [C12N 15/746 (2013.01); C12N 15/86 (2013.01); A61K 2039/552 (2013.01); C12N 2710/12022 (2013.01)] 11 Claims
OG exemplary drawing
 
1. An immunogenic composition comprising an adjuvant, and further comprising
two African swine fever virus peptides, polypeptides, and/or full-length proteins, comprising
one amino acid sequence which is at least 95% identical to MGF505-7R (SEQ ID NO: 774) and one amino acid sequence which is at least 95% identical to M448R (SEQ ID NOS: 568, 566).